EVALUATION OF PSYCHIATRIC DISABILITY AMONG PATIENTS WITH SCHIZOPHRENIA IN RELATION TO DURATION OF UNTREATED ILLNESS- A CROSS-SECTIONAL STUDY.

Sahoo S, Grover S, Dua D, et al. Concurrent validity of Indian Disability Evaluation and Assessment Scale with socio occupational functioning scale in patients with schizophrenia. Indian J Psychiatry 2017;59(1):106-10.            

Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 1991;17(2):325-51.                 

Wyatt RJ, Damiani LM, Henter ID. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment. British Journal of Psychiatry Suppl 1998;172(33):77-83.                    

McGlashan TH. Duration of untreated psychosis in first episode schizophrenia: marker or determinant of course? Biological Psychiatry 1999;46(7):899-907.                              

Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 1991;17(2):325-51.           

Takahashi T, Suzuki M, Tanino R, et al. Volume reduction of the left planum temporalegray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Res 2007;154(3):209-19.              

Lappin JM, Morgan K, Morgan C, et al. Graymatter abnormalities associated with duration of untreated psychosis. Schizophr Res 2006;83(2-3):145-53.      

Owens DC, Johnstone EC, Miller P, et al. Duration of untreated illness and outcome in schizophrenia: test of predictions in relation to relapse risk. The British Journal of Psychiatry 2010;196(4):296-301.            

Singh SP. Outcome measures in early psychosis: relevance of duration of untreated psychosis. British Journal of Psychiatry 2007;50:S58-S63.              

Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychological Medicine 2001;31(3):381-400.       

Craig TJ, Bromet EJ, Fennig S, et al. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? American Journal of Psychiatry 2000;157(1):60-6.            

De Haan L, van der Gaag M, Wolthaus J, Duration of untreated psychosis and the long-term course of schizophrenia. European Psychiatry 2000;15(4):264-7.      

Ho BC, Andreasen NC, Flaum M, et al. Untreated initial psychosis: Its relation to quality of life and symptom remission in first-episode schizophrenia. American Journal of Psychiatry 2000;157(5):808-15.               

Hoff AL, Sakuma M, Razi K, et al. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. American Journal of Psychiatry 2000;157(11):1824-8.           

Isaac M, Chand P, Murthy P, Schizophrenia outcome measures in the wider international community. British Journal of Psychiatry 2007;50:S71-7.    

Naheed M, Akter KA, Tabassum F, et al. Factors contributing the outcome of Schizophrenia in developing and developed countries: a brief review. International Current Pharmaceutical Journal 2012;1(4):81-5.            

Indian Disability Evaluation and Assessment Schedule. Rehabilitation committee of Indian psychiatric society 2001: p. 1-13.

Sudakar S, Chandrika PP, Anandan H. Clinical and social determinants of duration of untreated psychoses. International Journal of Scientific Study 2017;4(10):90-3.            

Loebel AD, Lieberman JA, Alvir JM, et al. Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry 1992;149(9):1183-8.            

Chang WC, Hui CL, Tang JY, et al. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study. Psychol Med 2013;43(9):1883-93.              

Carpiniello B, Pinna F, Tusconi M, et al. Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study. Article ID 576369, Schizophrenia Research and Treatment 2012;2012:1-8. 

Thara R, Kamath S. Women and schizophrenia. Indian J Psychiatry 2015;57(Suppl 2):S246-S51.    

Tirupati NS, Rangaswamy T, Raman P. Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Aust N Z J Psychiatry 2004;38(5):339-43.               

Padmavathi R, Rajkumar S, Srinivasan TN. Schizophrenic patients who were never treated – a study in an Indian urban community. Psychological Medicine 1998;28(5):1113-7.                   

Morgan C, Abdul-Al R, Lappin JM, et al. Clinical and social determinants of duration of untreated psychosis in the first-episode psychosis study. Br J Psychiatry 2006;189:446-52.   

Naheed M, Akter KA, Tabassum F, et al. Factors contributing the outcome of schizophrenia in developing and developed countries: a brief review, International Current Pharmaceutical Journal 2012;1(4):81-5.           

Thara R. Twenty-year course of schizophrenia: the Madras longitudinal study, Canadian Journal of Psychiatry 2004;49(8):564-9.         

Penttilä M, Jääskeläinen E, Hirvonen N, et al. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014;205(2):88-94.               

Rinaldi M, Killackey E, Smith J, et al. First episode psychosis and employment: a review. International Review of Psychiatry 2010;22(2):148-62.   

Raguram R, Venkateswaran A, Ramakrishna J, et al. Traditional community resources for mental health: a report of temple healing from India. BMJ 2002;325(7354):38-40. 

Gater R, de Almeida e Sousa B, Barrientos G, et al. The pathways to psychiatric care: a cross-cultural study. Psychol Med 1991;21(3):761-74.